A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants

Clinical trial NCT07462780 · RECRUITING

Trial details

NCT number: NCT07462780
Sponsor: Shenzhen Kangzhe Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Paroxysmal Nocturnal Hemoglobinuria, PNH Complement-mediated Kidney Disease

Start date: 2026-03-05
Primary completion: 2026-11-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.